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Available online 24 March 2016AbstractA galactose-specific lectin from Bauhinia monandra leaves (BmoLL) has been purified through ammonium sulfate fractionation followed by
guar gel affinity chromatography column. This study aimed to evaluate the potential anti-inflammatory and antinociceptive activity of pure
BmoLL in mice. Anti-inflammatory activity was evaluated by 1% carrageenan-induced inflammation in mice treated with BmoLL. Acetic acid-
induced abdominal writhing and hot plate methods evaluated antinociceptive activity. BmoLL significantly inhibited the carrageenan-induced
paw edema by 47% (30 mg/kg) and 60.5% (60 mg/kg); acetylsalicylic acid (ASA, 100 mg/kg) showed inhibition of 70.5%, in comparison
to controls. Leukocyte migration, an immune response to the inflammation process, was significantly reduced in presence of BmoLL; in mice
treated with ASA the decrease in leukocyte migration was similar to 15 mg/kg of the lectin. BmoLL at doses of 15, 30 and 60 mg/kg
significantly reduced the number of animal contortions by 43.1, 50.1 and 71.3%, respectively. BmoLL leukocyte migration was significantly
reduced; in mice treated with ASA the decrease in leukocyte migration was similar to 15 mg/kg of the lectin. BmoLL at doses of 15, 30 and
60 mg/kg significantly reduced the number of animal contortions by 43.1, 50.1 and 71.3%, respectively. The lectin (30 and 60 mg/kg) showed a
significant effect in the hot plate assay. BmoLL anti-inflammatory and antinociceptive effects were dose-dependent. The search for new and
natural compounds, with minimal side effects, to control pain and inflammation, is constantly increasing. BmoLL has great potential as a natural
anti-inflammatory product that can be explored for pharmacological purposes.
© 2016 The Authors. Published by Elsevier B.V. on behalf of Socie´te´ Franc¸aise de Biochimie et Biologie Mole´culaire (SFBBM). This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1. Introduction bonding, hydrophobic interactions and Van der Waals forcesLectins are proteins or glycoproteins of non-immunogenic
origin that possess carbohydrate-binding sites able to interact
reversibly and specifically with sugars through hydrogenAbbreviations: ASA, acetylsalicylic acid; BmoLL, Bauhinia monandra
leaf lectin; BmoRoL, Bauhinia monandra roots lectin; CcL, Caulerpa
cupressoides; CFAL, Clitoria fairchildiana; COX, cyclooxygenase; HA,
hemagglutinating activity; PEG2, prostaglandins.
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article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-n[1,2]. These proteins have been isolated from plants, micro-
organisms, higher fungus, lichens and animals [3]. They are
molecules of recognition ability within a cell, between cells or
organisms, and the interactions between carbohydrates and
lectins are an integral part of the host defense system [4]. In
plants, lectins are present in different tissues [5] and act as
defense proteins against phytophagous insects [6].
Studies focusing on the applications of plant lectins have
identified biological activities that may confer diverse phar-
macological properties to pure preparations obtained from
several vegetal parts such as seeds [7,8], bark [9] or leaves
[10]. Lectins can be insecticide [11,12] and, among others,nc¸aise de Biochimie et Biologie Mole´culaire (SFBBM). This is an open access
c-nd/4.0/).
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proliferative [16], antiplatelet aggregation [17,18], anti-
diabetic [19], antiparasite [20,7], wound healing [21] and
analgesic activities [22]. Also, these proteins from different
sources showed anti-inflammatory [23,4] and anti-nociceptive
properties [4,24]. A large amount of lectins are found in
Leguminosae plants, mainly in the subfamilie Papilionoideae,
but few lectins are from subfamilies Caesalpiniodeae and
Mimosoideae [25,26].
The genus Bauhinia (Caesalpiniodeae) is largely found in
tropical regions, including Africa, Asia and South America;
in Brazil, this plant is known as “cow's hoof” due to its leaf
shapes [27]. Plants from this genus acted as anti-diabetic
agents [28] and cause prolongation of blood coagulation
clotting [29]. Bauhinia monandra is a plant popularly known
in Brazil as “cow's hoof” and is widely used in folk medicine
for diabetes treatment; leaf extracts of B. monandra are
sources of natural antioxidants [30]. The Bauhinia lectins
have been isolated from B. purpurea [31], B. monandra [32],
B. variegata [33,26], B. bauhinioides [34], B. forficata [18]
and B. ungulata [8]. Two galactose-specific lectins were
isolated from B. monandra; the first was reported by Coelho
and Silva [27] and was purified from leaves (BmoLL); the
other lectin was purified from secondary roots (BmoRoL)
and showed termiticidal activity on Nasutitermes corniger
and antifungal activities against phytopathogenic species of
Fusarium [32]. Previous studies have reported some bio-
logical activities of BmoLL, such as an insecticidal action
[11], but there is no much information about the pharma-
cological activity of this lectin.
The inflammatory process consists in a protective response
to foreign and noxious stimulation and serves to eliminate the
initial cause of cell injury as well as the necrotic cells resulting
from the original aggression. This defense mechanism is
constituted by an innate system of cellular and humoral re-
sponses to an injury [35,36]. The classification of anti-
nociceptive drugs is usually based on their mechanism of
action either on the central nervous system or on the peripheral
nervous system [36]. The therapies currently available to treat
inflammation and pain are associated with side effects and low
efficacy. Thus, there is a great demand for new and more
effective anti-inflammatory compounds [4,35]. Herbal medi-
cines represent an alternative source of drugs to diseases
treatments. The present study aimed to investigate the in vivo
anti-inflammatory and antinociceptive potential of BmoLL in
mice.2. Materials and methods2.1. Chemicals and reagentsAcetylsalicylic acid (ASA), propylene glycol, and l-
carrageenan were purchased from Sigma Chemicals Co. (St.
Louis, MO, USA). Acetic acid, ether, chloroform, acetone,
methanol and other solvents were from Merck (Darmstadt,
Germany).2.2. Sample collection and BmoLL purificationA voucher specimen of B. monandra, number 57462, is
available at the Herbarium “Dardano de Andrade Lima” of the
“Instituto Agrono^mico de Pernambuco e IPA”, from Recife
City, State of Pernambuco, Brazil. B. monandra leaves were
collected from trees in Recife city, washed with distilled water,
dried at 28 C for 2e3 days, powdered, and extracted (10%, w/
v) at 4 C for 16 h in 10 mM citrate phosphate buffer con-
taining 150 mM NaCl, pH 6.5. The extract was fractionated
with ammonium sulfate (60% saturation) at 28 C for 4 h; after
centrifugation (12,000  g, 4 C, 15 min), the precipitate was
ressuspended in distilled water and dialyzed in the buffer. The
sample was applied into a guar gel affinity column made with
guar gum (Guaran; Sigma Chemical Co., St. Louis, MO,
USA); the column was previously equilibrated with the buffer.
After removal of unbound proteins, BmoLL was eluted with
330 mM galactose in the buffer (flow rate of 0.3 mL/min),
according to Coelho and Silva [27]. Hemagglutinating activity
(HA) of BmoLL was evaluated according to Coelho et al. [2];
protein concentration was quantified [37] and purified lectin
was stored at 20 C.2.3. AnimalsMale Swiss white mice (Mus musculus), 60 days old,
weighing 30 ± 5 g were obtained from the Laboratorio de
Imunopatologia Keizo Asami (LIKA) from the Universidade
Federal de Pernambuco (UFPE). The animals were separated
into groups (N ¼ 6) and housed in cages at a constant tem-
perature of 22 ± 2 C, with 12 h darkelight cycle, with free
access to standard chow (Labina, Agribands Brazil Ltd.) and
water ad libitum. The animals were fasted for 4 h prior use for
determination of anti-inflammatory and antinociceptive
activities.
All experimental procedures were performed according to
the National Institutes of Health guide for the care and use of
Laboratory animals (NIH Publications No. 8023, revised
1978) and the study was approved by the Ethics Committee for
Animal Care and Use (CEUA) of the Centro de Cie^ncias
Biologicas of UFPE (Of. number 259/10).2.4. Assay of BmoLL anti-inflammatory activity in
carrageenan-induced edemaCarrageenan was used to induce mice paw edema to eval-
uate the anti-inflammatory effect of BmoLL. The edema was
induced by the injection of freshly prepared solution of 1%
carrageenan (0.1 mL) in 0.9% NaCl, into the sub plantar tissue
of the right-hind paw of each mouse, half hour prior to
intraperitoneal administration of BmoLL [38]. Lectin doses
were chosen according to a pilot experiment; 3 groups of
animals (N ¼ 6) were treated with 15, 30 and 60 mg/kg
BmoLL (i.p.), a positive control group received 100 mg/kg
acetylsalicylic acid (ASA), and the negative control group
received just vehicle (0.9% NaCl).
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e Staineless Mardened) at 0, 1, 2, 3 and 4 h immediately after
the sub plantar injection of carrageenan, and the data obtained
for each animal were recorded. Increase in paw thickness
measured the difference in paw at 0 h and at the respective
experimental hours. The results obtained for the various
groups were reported as mean ± SD and expressed in milli-
meter. The percentage of inflammation inhibition was calcu-
lated according to equation (1) (Eq. (1)), where Vf and Vi
represent the initial and final paw thickness, respectively.
Inhibition of inflammation ð:%Þ
¼ VfVi

control group mean
 VfVi

test group mean

VfVi

control group mean

100
ð1Þ2.5. Assay of anti-inflammatory activity by carrageenan-
induced peritonitisPeritonitis was evaluated as described by Foster et al. [39].
Groups of animals (N ¼ 6) were deprived of food overnight
and pre-treated intraperitoneally with 0.9% NaCl (negative
control), ASA (positive control, 100 mg/kg) and BmoLL (15,
30 and 60 mg/kg). After 1 h the animals received an intra-
peritoneal (i.p.) injection of 1% carrageenan (1 mL). Four
hours later, the animals were sacrificed by cervical dislocation,
saline (2 mL) containing 1 mM EDTA was injected into the
peritoneal cavity and immediately a brief massage was made;
the peritoneal exudate was withdrawn and used for total
leukocyte cell, mainly neutrophils, counting in a Cell Counter
(ABX MICROS 60). The results were expressed as the number
of leukocytes  103/mm3.2.6. Assay of antinociceptive activity by acetic acid-
induced abdominal writhingAbdominal writhing was based on a contraction from the
abdominal muscle together with a stretching, induced by agent
nociceptive (0.8% acetic acid) with intraperitoneal injection
[40]. Groups of male mice received intraperitoneal injection ofTable 1
Effect of B. monandra leaf lectin (BmoLL) in the thickness of the right posterior
Treatment Edema thickness (mm)
T0 T1 T2 Edema
inhibition (%
Negative control 4.15 ± 0.14 5.27 ± 0.33 5.04 ± 0.28 e
ASA 4.16 ± 0.18 4.91 ± 0.15 4.62 ± 0.18 48
BmoLL (15 mg/kg) 3.86 ± 0.51 3.61 ± 0.22 4.18 ± 0.16 e
BmoLL (30 mg/kg) 2.92 ± 0.2 3.92 ± 0.2 3.83 ± 0.26* 18
BmoLL (60 mg/kg) 2.92 ± 0.2 4.5 ± 0.77 3.83 ± 0.41* 17
Values are expressed as mean ± SD. ANOVA: P < 0.05; *P < 0.001, in relation to
Animals with paw in normal conditions, without treatment; T1: Animal in treatmen
and T4: Animals in treatment (after 2, 3 and 4 h of carrageenan application) andBmoLL (15, 30 and 60 mg/kg), ASA (100 mg/kg) and saline
(negative control group) 1 h prior to administration of acetic
acid (0.8%, i.p.). The number of writhing reflexes was counted
for 20 min. A significant reduction of writhes in animals
treated with BmoLL compared to those in the negative control
group was considered as an antinociceptive response.2.7. Assay of antinociceptive activity by hot plate testThe hot plate test was done applying the central analgesic
activity against thermal stimuli [41]. The animals were indi-
vidually placed in a hot plate heated at 55 ± 1 C and the
response was measured at 0, 30, 60, 90 and 120 min after the
first thermal stimulus. The maximum exposure time of the
animal on the hot plate was 60 s to avoid damage. A negative
control group was treated with saline, a positive control group
was treated with morphine (1 mg/kg, i.p.), and the assayed
groups received BmoLL (15, 30 and 60 mg/kg; i.p.) 1 h before
performing experiments.2.8. Statistical analysisThe results obtained for the various groups were presented
as mean ± standard deviation (SD). Statistical evaluation was
carried out by one-way analysis of variance ANOVA, followed
by Tukey's post hoc test with the significance level set at
P < 0.05 using PRISMA (GraphPad Software, Inc., San
Diego, CA, version 5.01).
3. Results3.1. Anti-inflammatory activity by carrageenan-induced
paw edema and carrageenan-induced peritonitisInjection of 1% carrageenan into the mice hind paw
induced edema and reached a maximum level at 1 h after
administration, and then the edema decreased over the sub-
sequent hours, except when BmoLL was administered at a
dose of 15 mg/kg. Administration of BmoLL showed a sig-
nificant (P < 0.05) anti-inflammatory activity (BmoLL 30 and
60 mg/kg) reducing the paw edema in a dose dependent
manner (Table 1). Two hours after carrageenan application a
reduction of the paw edema was observed with animals treatedpaw edema of mice.
)
T3 Edema
inhibition (%)
T4 Edema inhibition (%)
4.79 ± 0.11 e 4.71 ± 0.07 e
4.35 ± 0.16¥ 70 4.35 ± 0.14¥ 65
4.29 ± 0.26¥ 32.6 4.19 ± 0.25¥ 40.9
3.25 ± 0.27* 47.3 3.08 ± 0.20* 69.6
3.17 ± 0.26* 60.5 3.08 ± 0.20* 69.6
control group. Animals treated 1 h before induction of edema. T: time (h). T0:
t (after 1 h of carrageenan application) and with paw edema beginning; T2, T3
with the paw edema reduction. ASA: Acetylsalicylic acid.
Fig. 1. Effect of BmoLL in leukocyte migration in the model of carrageenan-
induced peritonitis. Negative control: NaCl 0.9%; ASA: acetylsalicylic acid
(positive control). Values are expressed as mean ± standard deviation. Sig-
nificant difference in comparison to the control group: *P < 0.0001.
Fig. 2. Effect of BmoLL in the number of writhes in the model of nociception
induced by acetic acid. ASA, acetylsalicylic acid. Values are expressed as
mean ± standard deviation. Significant difference in comparison to the control
group: *P < 0.0001.
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edema reduction was observed with BmoLL in these doses.
The animals treated with ASA 100 mg/kg (positive control)
showed the best result after 3 h of carrageenan application.
Leukocyte migration through activated venular walls is a
fundamental immune response to an inflammation process that
is prerequisite to the entry of effector cells such as neutrophils,
monocytes, and effector T cells to sites of infection, injury,
and stress [42]. The induction of inflammation with carra-
geenan into the peritoneal cavity caused a migration of leu-
kocytes. In a dose-dependent manner, BmoLL (15, 30 and
60 mg/kg) significantly reduced the leukocyte migration (43.5,
54.9, and 60.9%, respectively) when compared with the
negative control group (saline), as shown in Fig. 1. In the
peritoneal fluid of the group treated with ASA (100 mg/kg)
there was a decrease in leukocyte cellular migration, similar to
the group treated with BmoLL 15 mg/kg. BmoLL showed a
significant (P < 0.05) anti-inflammatory activity in the mice
peritoneal cavity.3.2. Antinociceptive activity by acetic acid-induced
abdominal writhing and by hot plate testFig. 3. Analgesic effect of BmoLL in latency time in the hot plate assay on
mice. ASA, acetylsalicylic acid. Values are expressed as mean ± standard
deviation. Significant difference in comparison to the control group:
*P < 0.001.The administration of BmoLL in different concentrations
(15, 30 and 60 mg/kg) showed a significant reduction (43.1,
54.2 and 71.3%, respectively) in the writhing induced by
acetic acid administration, compared with the negative control
group treated with saline (Fig. 2). The group treated with ASA
(100 mg/kg), the positive control for anti-nociception, showed
significant decrease (92.7%) of writhing.
Fig. 3 shows the analgesic response of groups treated with
three concentrations of BmoLL. The group of mice treatedwith a dose of 30 and 60 mg/kg (i.p.) revealed a significant
analgesic response (P < 0.001) compared to the negative
control (saline), in the form of increased reaction time of mice
to jump or lick paws in hot plate method after 90 min Mac-
Donald et al. [41]. The result with BmoLL 60 mg/kg was
similar to that observed for the group treated with the standard
drug (morphine 1 mg/kg) after 90 and 120 min. There was no
analgesic response for the group treated with low dose of
BmoLL (15 mg/kg).
4. Discussion
Carrageenan-induced paw edema is a most-valuable
model to investigate anti-inflammatory effect of natural and
chemical products. Inflammatory reactions, characterized by
vascular and cellular events, have an important role in the
activation of cyclooxygenase (COX) resulting in the release
of inflammatory mediators such as prostaglandins and
66 J.K.L. Campos et al. / Biochimie Open 2 (2016) 62e68leukotrienes. Considering the significant effect presented by
BmoLL to reduce substantially paw edema induced by
carrageenan, analyzed at different times, we can assume that
this lectin may have inhibitory action on the release of in-
flammatory mediators. Sisenando et al. [43] showed that
BmoLL was unable to produce genotoxicity or cytotoxicity
effects.
The anti-inflammatory activity of BmoLL corroborate with
the lectin purified from the seeds of Clitoria fairchildiana
(CFAL), which showed anti-inflammatory activity of 64% on
paw edema induced by carrageenan [22]. Previous studies
showed that some lectins have anti-inflammatory activity by
reducing the rolling and adhesion of neutrophils on the
endothelium, which may possibly be due to a competitive
inhibition of glycosylated selectin binding sites on the mem-
branes of leukocytes and endothelial cells. Thus, it is sug-
gested that lectins can inhibit the vascular inflammation
mediated by adhesion of immune cells [44,45]. Therefore, we
can suppose that the anti-inflammatory potential of BmoLL
may be a result of vascular inflammation inhibition by adhe-
sion of immune cells to endothelium.
In addition to the vascular inflammation processes, the
migration of leukocytes is a key factor for promoting the in-
flammatory process [46]. Thus, by using the model of perito-
neum inflammation to evaluate the migration of leukocytes in
inflammatory response it was demonstrated in this study that
BmoLL significantly reduced cell infiltration in all assayed
doses by 43.1, 54.2 and 71.3%. Leite et al. [22] showed that
lectin from the seeds of C. fairchildiana (CFAL) also decreased
the leukocytes number in the peritoneal cavities by about 29%.
Experimental studies have demonstrated the inhibition of
leukocyte migration by different anti-inflammatory mecha-
nisms. Napimoga et al. [46] demonstrated that Lonchocarpus
sericeus lectin decreased leukocytemigration and inflammatory
response via inhibition of cytokine and chemokine production.
In this context, lectin from Luetzelburgia auriculata seeds
promotes reduction of inflammation by inhibiting adhesion and
rolling of leukocytes, and modulates histamine and prosta-
glandins (PEG2) in inflammation animal models [47]. There-
fore, we can suppose that the peritoneum inflammation
inhibitionmediated by administration ofBmoLLmay be a result
of reduction of cytokines and chemokines release involved with
the leukocytes migration.
The experimental model of writhing by injecting of an
irritant product such as acetic acid in mice is a chemical
method used to assess nonspecific central and peripheral
analgesic activity [48] of the test product, which infers from
the reduction in writhing frequency. There will be an increase
in the peritoneal fluid by inducing the release of chemical
mediators and therefore a direct stimulus via activation of
chemo sensitive nociceptors [49]. Therefore, the analgesic
effect presented by BmoLL may be due to the anti-
inflammatory effect in the inhibition of these mediators.
Recently, studies have shown that plant lectins can display
antinociceptive effect via lectin domain interaction [22].
Considering the clear association between inflammatory pro-
cesses and development of pain, a classical sign ofinflammation, the BmoLL antinociceptive effects may be
associated directly with decreasing inflammation. These re-
sults corroborated with the C. fairchildiana lectin that also
showed significant antinociceptive effects, at all doses tested
(0.1, 1 and 10 mg/kg) and this effect also could be associated
to anti-inflammatory action [22]. Lectins from seeds of L.
sericeus and Canavalia boliviana showed antinociceptive ac-
tivity associated with inhibitory effects on leukocyte migration
and hipernociception via inhibition of cytokine and chemokine
production [46,50]. Lectin from the green marine alga Cau-
lerpa cupressoides (CcL, 3, 9 or 27 mg/kg) also reduced the
number of writhes induced by acetic acid by 37.2%; 53.5%
and 86.0%, respectively [4].
On the other hand, model nociception from a thermal
stimulus is commonly used for evaluating the central anal-
gesic effect. In the present work, we could observe that
BmoLL was able to increase the latency time and the best
results were found when the animals were treated with higher
doses (30 and 60 mg/kg). Consistent with the findings re-
ported here, other studies with lectins obtained from Bry-
thamnion seaforthii [51], C. boliviana [50], and Canna
limbata [52] observed a significant increase in the latency
time of animals on the hot plate. In this method, the thermal
sensation stimulates sensory fibers run through synapses to
the cortex, resulting in the perception of warmth. The anti-
nociceptive activity of BmoLL is already associated with
peripheral analgesic activity. Our findings may also be
attributed to a direct BmoLL effect on specific central nervous
system receptors related to opioid molecules which may act as
an antagonist binding to stereo specific and saturable receptor
sites in the brain, spinal cord and other tissues, providing the
relieve of pain, as proposed with Canavalia brasiliensis lectin
by Pires et al. [53]. Therefore, our study demonstrates that
BmoLL have antinociceptive effect not only on the peripheral
system, but also on the central nervous system. Moreover,
reinforcing the hypothesis that antinociceptive response of
lectin may be explained by their specificity for different
sugars, which could enhance the lectin-carbohydrate interac-
tion and cell receptors.
5. Conclusions
BmoLL has potent anti-inflammatory and antinociceptive
properties and this could explain the basis for the use of B.
monandra in folk medicine. Furthermore, the results provided
experimental evidence for the effectiveness of the traditional
use of B. monandra in treating diseases associated with
inflammation and pain, and that BmoLL may have potential to
be used as a natural anti-inflammatory product for pharma-
cological purposes.
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